Go Pro
BATS:ARKG

ARK Genomic Revolution ETF (ARKG) Price, Holdings, & News

ARK Genomic Revolution ETF logo
$48.29 +0.58 (+1.21%)
As of 11:35 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About ARK Genomic Revolution ETF (BATS:ARKG)

Advanced

Key Stats

Today's Range
$47.90
$49.17
50-Day Range
$37.50
$50.06
52-Week Range
$24.60
$50.53
Volume
1.53 million shs
Average Volume
3.09 million shs
Market Capitalization
$2.16 billion
Assets Under Management
$1.91 billion
Dividend Yield
N/A
Net Expense Ratio
0.75%
Aggregate Rating
Moderate Buy

ETF Overview

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

ARK Genomic Revolution ETF Expenses

TypeARKGTheme ETFsEquity ETFsBATS ETFsAll ETFs
Management Fee0.75%0.57%0.57%0.59%0.53%
Other Expenses0.00%0.57%0.53%0.49%0.54%
Total Expense0.75%0.72%0.75%0.73%0.73%
Fee Waiver0.00%-0.72%-0.67%-0.54%-0.68%
Net Expense0.75%0.60%0.63%0.66%0.60%
Receive ARKG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARKG ETF News Headlines

The national debt just passed $39 trillion
The U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40 trillion by fall. Servicing that debt now costs more than the entire defense budget, while inflation above 3.5% keeps eroding cash savings. Central banks are responding by buying gold at the fastest pace in decades. The U.S. Gold Bureau's complimentary guide covers IRA-eligible gold and silver options, secure storage, and a fast BuyBack Guarantee.tc pixel
ARKG: Dividendenhistorie, Rendite und Ex-Dividenden-Tag
See More Headlines

ARKG ETF - Frequently Asked Questions

ARK Genomic Revolution ETF's stock was trading at $28.9250 at the beginning of the year. Since then, ARKG stock has increased by 64.9% and is now trading at $47.71.

Top institutional shareholders of ARK Genomic Revolution ETF include Baird Financial Group Inc. (0.16%), Client First Investment Management LLC (0.14%), Turner Financial Group Inc. (0.09%) and Nwam LLC (0.07%).

Shares of ARKG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ARK Genomic Revolution ETF investors own include Invesco QQQ (QQQ), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AbbVie (ABBV) and PayPal (PYPL).

Fund Details

Issuer
ARK
Fund Name
ARK Genomic Revolution ETF
Tax Classification
Regulated Investment Company
Stock Exchange
BATS
Current Symbol
BATS:ARKG
Inception Date
10/31/2014
Fund Manager
Catherine Wood
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
35

Fund Statistics

Assets Under Management
$1.91 billion
Average Daily Volume
$4.16 million
Discount/Premium
-0.04%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
ARK Investment Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
4,404
Put Options
1,740
Call Options
2,664
Short Interest
27,229,407 shs

Miscellaneous

Beta
1.62
Creation Fee
$500.00
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Top 10 ARKG Holdings

ARKG Sector Exposure

ARKG Industry Exposure


This page (BATS:ARKG) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners